Radiotracer dose reduction in integrated PET/MR: Implications from National Electrical Manufacturers Association phantom studies

Journal of Nuclear Medicine

Volumn 55, Issue 8, 2014, Pages 1361-1367

  Oehmigen, Mark ^a,b,c   Ziegler, Susanne ^a   Jakoby, Bjoern W ^d,e   Georgi, Jens Christoph ^d   Paulus, Daniel H ^a   Quick, Harald H ^a,b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d SIEMENS AG   (Germany)

^e UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Integrated PET MR hybrid imaging; NEMA image quality measurements; PET MR phantom measurements; Radiotracer dose reduction

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER;

ARTICLE; BACKGROUND VARIABILITY; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION RESPONSE; CONTRAST RECOVERY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG HALF LIFE; IMAGE QUALITY; IMAGING AND DISPLAY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SIGNAL NOISE RATIO; DEVICES; HUMAN; IMAGE PROCESSING;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOACTIVE TRACERS;

EID: 84905496349     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.114.139147     Document Type: Article

References (14)

1. Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumor PET imaging-version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181-200.
2. Drzezga A, Souvatzoglou M, Eiber M, et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med. 2012;53:845-855.
3. Quick HH, von Gall C, Zeilinger M, et al. Integrated whole-body PET/MR hybrid imaging: clinical experience. Invest Radiol. 2013;48:280-289.
4. Martinez-Möller A, Eiber M, Nekolla SG, et al. Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology. J Nucl Med. 2012;53:1415-1426.
5. Hartung-Knemeyer V, Beiderwellen KJ, Buchbender C, et al. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging. Invest Radiol. 2013;48:290-294.
6. National Electrical Manufacturers Association. NEMA standards publication NU 2-2007. Performance Measurements of Positron Emission Tomographs. Rosslyn, VA: NEMA; 2007:26-33.
7. Delso G, Fürst S, Jakoby B, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52:1914-1922.
8. Pichler BJ, Judenhofer MS, Catana C, et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med. 2006;47:639-647.
9. Martinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50:520-526.
10. Delso G, Martinez-Möller A, Bundschuh RA, et al. Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner. Phys Med Biol. 2010;55:4361-4374.
11. Paulus DH, Tellmann L, Quick HH. Towards improved hardware component attenuation correction in PET/MR hybrid imaging. Phys Med Biol. 2013;58:8021-8040.
12. Ziegler S, Braun H, Ritt P, et al. Systematic evaluation of phantom fluids for simultaneous PET/MR hybrid imaging. J Nucl Med. 2013;54:1464-1471.
13. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671-675.
14. Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42:1412-1417.